Opicapone Impurity 3
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1402714-31-1Opicapone Impurity 3

● In Stock

Catalogue No.:VE0023380
CAS No.:1402714-31-1
Mol. Formula:C15H11ClN4O7
Mol. Weight:394.7 g/mol

Additional information on CAS 1402714-31-1

Parent drug

Opicapone

IUPAC Name

3-Chloro-5-(5-(3, 4-dihydroxy-5-nitrophenyl)-1, 2, 4-oxadiazol-3-yl)-6-hydroxy-2, 4-dimethylpyridine 1-oxide

Pharmacopoeial Synonyms

N/A

Other Synonyms

1, 2-Benzenediol, 5-[3-(5-chloro-2-hydroxy-4, 6-dimethyl-1-oxido-3-pyridinyl)-1, 2, 4-oxadiazol-5-yl]-3-nitro;

Smiles

CC1=C(Cl)C(C)=[N+]([O-])C(O)=C1C2=NOC(C3=CC([N+]([O-])=O)=C(O)C(O)=C3)=N2

InChI

InChI=1S/C15H11ClN4O7/c1-5-10(15(23)19(24)6(2)11(5)16)13-17-14(27-18-13)7-3-8(20(25)26)12(22)9(21)4-7/h3-4, 21-23H, 1-2H3

Description

Opicapone Impurity 3 is a well-characterized reference material that meets stringent regulatory standards set by USP | EMA | JP | and BP. It plays a key role in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial production of Opicapone. To ensure accuracy and reliability across various analytical applications | it includes a comprehensive Structure Elucidation Report (SER) | providing valuable insights for quality control and method development.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url